Economic valuation of environmental benefits of removing pharmaceutical and personal care products from WWTP effluents by ozonation

Science of the Total Environment

Volumn 461-462, Issue , 2013, Pages 409-415

  Molinos Senante, M ^a   Reif, R ^c,d   Garrido Baserba, M ^b,c   Hernandez Sancho F ^a   Omil, F ^d   Poch, M ^b,c   Sala Garrido, R ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b CATALAN INSTITUTE FOR WATER RESEARCH ICRA   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

^d UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Environmental benefits; Ozonation; Post treatment; PPCPs; Shadow prices; Wastewater treatment

Indexed keywords

DRINKING WATER PRODUCTION; ENVIRONMENTAL BENEFITS; PHARMACEUTICAL AND PERSONAL CARE PRODUCTS; POST TREATMENT; PPCPS; SHADOW PRICE; WASTEWATER TREATMENT PLANTS; WATER FRAMEWORK DIRECTIVES;

ECONOMIC ANALYSIS; ENVIRONMENTAL REGULATIONS; OZONE; OZONIZATION; SURFACE WATERS; WASTEWATER TREATMENT; WATER CONSERVATION; WATER POLLUTION;

EFFLUENTS;

DICLOFENAC; ETHINYLESTRADIOL; FRAGRANCE; GALAXOLIDE; SULFAMETHOXAZOLE; SURFACE WATER; TONALIDE; UNCLASSIFIED DRUG;

DRUG; EFFLUENT; OZONE; REGULATORY FRAMEWORK; VALUATION; WASTE TREATMENT; WASTEWATER;

ARTICLE; ECONOMIC EVALUATION; EFFLUENT; ENVIRONMENTAL ECONOMICS; OZONATION; PRIORITY JOURNAL; REACTOR; WASTE COMPONENT REMOVAL; WASTE WATER MANAGEMENT;

ENVIRONMENTAL BENEFITS; OZONATION; POST-TREATMENT; PPCPS; SHADOW PRICES; WASTEWATER TREATMENT;

BIOREACTORS; COSMETICS; MEMBRANES, ARTIFICIAL; MODELS, ECONOMIC; MOLECULAR STRUCTURE; OZONE; PHARMACEUTICAL PREPARATIONS; WASTE DISPOSAL, FLUID; WASTE WATER; WATER PURIFICATION;

EID: 84878889857     PISSN: 00489697     EISSN: 18791026     Source Type: Journal    
DOI: 10.1016/j.scitotenv.2013.05.009     Document Type: Article

References (49)

1. Artola-Garicano E., Borkent I., Hermens J.L.M., Vaes W.H.J. Removal of two polycyclic musks in sewage treatment plants: freely dissolved and total concentrations. Environ Sci Technol 2003, 37:3111-3116.
2. Caballero R., Gil A., Fernandez-Santos X. An experts' survey on sustainability across twenty-seven extensive European systems of grassland management. Environ Manag 2008, 42(2):190-199.
3. Camacho-Muñoz M.D., Santos J.L., Aparicio I., Alonso E. Presence of pharmaceutically active compounds in Doñana Park (Spain) main watersheds. J Hazard Mater 2010, 177:1159-1162.
4. Campbell H.F. The shadow-price of labour and employment benefits in a developing economy. Aust Econ Pap 2008, 47(4):311-319.
5. Chase D.A., Karnjanapiboonwong A., Fang Y., Cobb G.P., Morse A.N., Anderson T.A. Occurrence of synthetic musk fragrances in effluent and non-effluent impacted environments. Sci Total Environ 2012, 416:253-260.
6. Clara M., Windhofer G., Weilgony P., Gans O., Denner M., Chovanec A., et al. Identification of relevant micropollutants in Austrian municipal wastewater and their behaviour during wastewater treatment. Chemosphere 2012, 87(11):1265-1272.
7. 2 allowances. J Environ Econ Manag 1996, 30(5):58-72.
8. Comeau F., Surette C., Brun G.L., Losier R. The occurrence of acidic drugs and caffeine in sewage effluents and receiving waters from three coastal watersheds in Atlantic Canada. Sci Total Environ 2008, 396(2-3):132-146.
9. Dantas R.F., Contreras S., Sans C., Esplugas S. Sulfamethoxazole abatement by means of ozonation. J Hazard Mater 2008, 150(3):790-794.
10. de la Cruz N., Gimenez J., Esplugas S., Grandjean D., De Alencastro L.F., Pulgarin C. Degradation of 32 emergent contaminants by UV and neutral photo-Fenton in domestic wastewater effluent previously treated by activated sludge. Water Res 2012, 46(6):1947-1957.
11. Deborde M., Rabouan S., Duguet J.P., Legube B. Kinetics of aqueous ozone-induced oxidation of some endocrine disruptors. Environ Sci Technol 2005, 39(16):6086-6092.
12. Dodd M.C., Buffle M.O., von Gunten U. Oxidation of antibacterial molecules by aqueous ozone: moiety-specific reaction kinetics and application to ozone-based wastewater treatment. Environ Sci Technol 2006, 40(6):1969-1977.
13. Dodd M.C., Kohler H.P.E., von Gunten U. Oxidation of antibacterial compounds by ozone and hydroxyl radical: elimination of biological activity during aqueous ozonation processes. Environ Sci Technol 2009, 43(7):2498-2504.
14. Dolar D., Vukovic A., Asperger D., Kosutic K. Effect of water matrices on removal of veterinary pharmaceuticals by nanofiltration and reverse osmosis membranes. J Environ Sci 2011, 23(8):1299-1307.
15. EPA Wastewater technology fact sheet. Ozone disinfection. EPA 832-F-99-063 1999, EPA.
16. EUROSTAT Energy price statistics Available at:. http://epp.eurostat.ec.europa.eu/statistics_explained/index.php/Energy_price_statistics#Further_Eurostat_information.
17. Färe R., Grosskopf S. Modeling undesirable factors in efficiency evaluation: comment. Eur J Oper Res 2004, 157(1):242-245.
18. Färe R., Grosskopf S., Lovell C.A.K., Yaisawarng S. Derivation of shadow prices for undesirable outputs: a distance function approach. Rev Econ Stat 1993, 75(2):374-380.
19. Gabet-Giraud V., Miège C., Choubert J.M., Ruel S.M., Coquery M. Occurrence and removal of estrogens and beta blockers by various processes in wastewater treatment plants. Sci Total Environ 2010, 408(19):4257-4269.
20. Hernández-Sancho F., Molinos-Senante M., Sala-Garrido R. Economic valuation of environmental benefits from wastewater treatment processes: an empirical approach for Spain. Sci Total Environ 2010, 408:953-957.
21. Horii Y., Reiner J.L., Loganathan B.G., Kumar K.S., Sajwan K., Kannan K. Occurrence and fate of polycyclic musks in wastewater treatment plants in Kentucky and Georgia, USA. Chemosphere 2007, 68:2011-2020.
22. Huber M.M., Canonica S., Park G.Y., von Gunten U. Oxidation of pharmaceuticals during ozonation and advanced oxidation processes. Environ Sci Technol 2003, 37(5):1016-1024.
23. Janzen N., Dopp E., Hesse J., Richards J., Türk J., Bester D. Transformation products and reaction kinetics of fragrances in advanced wastewater treatment with ozone. Chemosphere 2011, 85:1481-1486.
24. Jones O.A.H., Green P.G., Voulvoulis N., Lester J.N. Questioning the excessive use of advanced treatments to remove organic micropollutants from wastewater. Environ Sci Technol 2007, 41(14):5085-5089.
25. Krichevskaya M., Klauson D., Portjanskaja E., Preis S. The cost evaluation of advanced oxidation processes in laboratory and pilot-scale experiments. Ozone Sci Eng 2011, 33(3):211-223.
26. Kumbhakar S.C., Lovell C.A.K. Stochastic frontier analysis 2000, Cambridge University Press, Cambridge.
27. Lee C.O., Howe K.J., Thomson B.M. Ozone and biofiltration as an alternative to reverse osmosis for removing PPCPs and micropollutants from treated wastewater. Water Res 2012, 46(4):1005-1014.
28. Liao C.N., Önal H., Chen M.H. Average shadow price and equilibrium price: a case study of tradable pollution permit markets. Eur J Oper Res 2009, 196(3):1207-1213.
29. Lopez-Muñoz M.J., Sotto A., Arsuaga J.M. Nanofiltration removal of pharmaceutically active compounds. Desalin Water Treat 2012, 42(1-3):138-143.
30. Molinos-Senante M., Hernández-Sancho F., Sala-Garrido R. Estudio de viabilidad del proceso de recuperación del fósforo contenido en las aguas residuales: una aproximación económica Rect@ 2010, 11:179-195. [In Spanish].
31. Molinos-Senante M., Hernández-Sancho F., Sala-Garrido R. Economic feasibility study for wastewater treatment: a cost-benefit analysis. Sci Total Environ 2010, 408:4396-4402.
32. Molinos-Senante M., Hernández-Sancho F., Sala-Garrido R. Cost-benefit analysis of water-reuse projects for environmental purposes: a case study for Spanish wastewater treatment plants. J Environ Manage 2011, 92:3091-3097.
33. Molinos-Senante M., Hernández-Sancho F., Sala-Garrido R. Assessing disproportionate costs to achieve good ecological status of water bodies in a Mediterranean river basin. J Environ Monit 2011, 13(8):2091-2101.
34. Nöthe T., Hartmann D., von Sonntag J., von Sonntag C., Fahlenkamp H. Elimination of the musk fragrances galaxolide and tonalide from wastewater by ozonation and concomitant stripping. Water Sci Technol 2007, 55(12):287-292.
35. Owen R., Jobling S. Environmental science: the hidden costs of flexible fertility. Nature 2012, 485:441.
36. Petrovic M., De Alda M.J.L., Diaz-Cruz S., Postigo C., Radjenovic J., Gros M., et al. Fate and removal of pharmaceuticals and illicit drugs in conventional and membrane bioreactor wastewater treatment plants and by riverbank filtration. Philos Trans R Soc Lond 2009, 367(1904):3979-4003.
37. Radjenovic J., Petrovic M., Ventura F., Barceló D. Rejection of pharmaceuticals in nanofiltration and reverse osmosis membrane drinking water treatment. Water Res 2008, 42(14):3601-3610.
38. Reif R., Suarez S., Omil F., Lema J.M. Fate of pharmaceuticals and cosmetic ingredients during the operation of a MBR treating sewage. Desalination 2008, 221:511-517.
39. Reif R., Santos A., Judd S.J., Lema J.M., Omil F. Occurrence and fate of pharmaceutical and personal care products in a sewage treatment works. J Environ Monit 2011, 13:137-144.
40. Rodríguez I., Quintana J.B., Carpinteiro J., Carro A.M., Lorenzo R.A., Cela R. Determination of acidic drugs in sewage water by gas chromatography-mass spectrometry as tert-butyldimethylsilyl derivates. J Chromatogr A 2003, 985:265-274.
41. Shephard R.W. Theory of cost and production functions 1970, Princeton University Press, Princeton.
42. Snyder S.A., Wert E.C., Rexing D.J., Zegers R.E., Drury D.D. Ozone oxidation of endocrine disruptors and pharmaceuticals in surface water and wastewater. Ozone Sci Eng 2006, 28(6):445-460.
43. Stalter D., Magdeburg A., Weil M., Knacker T., Oehlmann J. Toxication or detoxication? In-vivo toxicity assessment of ozonation as advanced wastewater treatment with the rainbow trout. Water Res 2010, 44(2):439-448.
44. Suarez S., Dodd M.C., Omil F., von Gunten U. Kinetics of triclosan oxidation by aqueous ozone and consequent loss of antibacterial activity: relevance to municipal wastewater ozonation. Water Res 2007, 41(12):2481-2490.
45. Suárez S., Carballa M., Omil F., Lema J. How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters?. Rev Environ Sci Biotechnol 2008, 7(2):125-138.
46. Vanderford B.J., Pearson R.A., Rexing D.J., Snyder S.A. Analysis of endocrine disruptors, pharmaceuticals, and personal care products in water using liquid chromatography/tandem mass spectrometry. Anal Chem 2003, 75:6265-6274.
47. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment-a review. Sci Total Environ 2012, 429:123-155.
48. Vogna D., Marotta R., Napolitano A., Andreozzi R., d'Ischia M. Advanced oxidation of the pharmaceutical drug diclofenac with UV/H202 and ozone. Water Res 2004, 38(2):414-422.
49. Yin Z., Wang X. The study on the effect of shadow price in emission trading 2010. ICAMS 2010 - Proceedings of 2010 IEEE International Conference on Advanced Management Science 2010, 2:514-516. [art. No. 552975].